Slama J T, Simmons A M
Department of Biochemistry, University of Texas Health Science Center, San Antonio 78284-7760.
Biochemistry. 1991 Mar 5;30(9):2527-34. doi: 10.1021/bi00223a033.
Two new photoactive analogues of oxidized nicotinamide adenine dinucleotide (NAD+) which are resistant to cleavage by NAD glycohydrolase were synthesized and characterized. The beta-D-ribonucleotide ring of the nicotinamide riboside moiety of NAD+ was replaced with a 2,3-dihydroxycyclopentane ring forming a carbocyclic dinucleotide analogue. Photoreactivity was achieved by the incorporation of an azido group at the 8-position of the adenosyl ring. The previously published synthesis of carbocyclic pyridine dinucleotide analogues [Slama, J. T., & Simmons, A. M. (1988) Biochemistry 27, 183] was modified by resolving the carbocyclic 1-aminoribose analogues and producing optically pure (+)-(1S)- or (-)-(1R)-4 beta-amino-2 alpha,3 alpha-dihydroxy-1 beta-cyclopentanemethanol. Each of these was converted to the corresponding carbocyclic nicotinamide 5'-nucleotide analogue and coupled with 8-azidoadenosine 5'-monophosphate. Two photoactive and isomeric NAD+ analogues were thus prepared. 8-Azidoadenosyl carba-NAD is the analogue in which D-dihydroxycyclopentane is substituted for the D-ribose of the nicotinamide nucleoside moiety. 8-Azido-adenosyl pseudocarba-NAD contains the L-carbocycle in place of the D-ribotide ring. 8-Azidoadenosyl carba-NAD was shown to inhibit the NAD glycohydrolase from Bungarus fasciatus venom competitively with an inhibitor dissociation constant of 187 microM. 8-Azidoadenosyl pseudocarba-NAD was shown to inhibit the same enzyme competitively with a Ki of 73 microM. The superior NADase inhibitor, 8-azidoadenosyl pseudocarba-NAD, was characterized kinetically and shown to fulfill the criteria required of a specific active site directed photoaffinity probe. Irradiation of mixtures of the photoprobe and NAD glycohydrolase with short-wave ultraviolet light resulted in the rapid and irreversible loss of enzyme activity.(ABSTRACT TRUNCATED AT 250 WORDS)
合成并表征了两种对烟酰胺腺嘌呤二核苷酸(NAD+)氧化产物具有抗性且不被NAD糖水解酶裂解的新型光活性类似物。NAD+烟酰胺核糖部分的β-D-核糖核苷酸环被2,3-二羟基环戊烷环取代,形成一种碳环二核苷酸类似物。通过在腺苷环的8位引入叠氮基实现光反应活性。对先前发表的碳环吡啶二核苷酸类似物的合成方法[斯拉马,J.T.,& 西蒙斯,A.M.(1988年)《生物化学》27卷,183页]进行了改进,通过拆分碳环1-氨基核糖类似物并制备光学纯的(+)-(1S)-或(-)-(1R)-4β-氨基-2α,3α-二羟基-1β-环戊烷甲醇。将其中每一种转化为相应的碳环烟酰胺5'-核苷酸类似物,并与8-叠氮腺苷5'-单磷酸偶联。由此制备了两种光活性且异构的NAD+类似物。8-叠氮腺苷碳环-NAD是一种类似物,其中D-二羟基环戊烷取代了烟酰胺核苷部分的D-核糖。8-叠氮-腺苷假碳环-NAD含有L-碳环以取代D-核糖核苷酸环。已证明8-叠氮腺苷碳环-NAD以187微摩尔的抑制剂解离常数竞争性抑制银环蛇毒液中的NAD糖水解酶。已证明8-叠氮腺苷假碳环-NAD以73微摩尔的抑制常数竞争性抑制同一种酶。性能更优的NAD酶抑制剂8-叠氮腺苷假碳环-NAD进行了动力学表征,并显示符合特定活性位点导向光亲和探针所需的标准。用光探针和NAD糖水解酶的混合物进行短波紫外线照射导致酶活性迅速且不可逆丧失。(摘要截短于250字)